DIANA MULLIKIN: Open Payments
NPI 1770243321 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,745 in 114 payments from 18 companies in 2025. Trend: 2023 $1,041 · 2024 $3,241 · 2025 $2,745
Food & beverage: $2,475Education: $270
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $539 |
| ABBVIE INC. | 26 | $514 |
| PFIZER INC. | 16 | $364 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $229 |
| E.R. Squibb & Sons, L.L.C. | 12 | $201 |
| Amgen Inc. | 7 | $171 |
| Incyte Corporation | 4 | $167 |
| GENZYME CORPORATION | 3 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| UCB, Inc. | 3 | $75 |
Products named: TREMFYA, RINVOQ, CIBINQO, SKYRIZI, DUPIXENT, Sotyktu, OTEZLA, OPZELURA.
Industry payments across SC — which companies pay providers there.
